NAFDAC Issues Warning About Circulation of Counterfeit Injections
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised alarm over a batch of counterfeit Meronem 1g injections that is currently in circulation. In a public alert memo released, the agency’s Director-General, Prof. Mojisola Adeyeye, said the Marketing Authorization Holder (MAH), Pfizer, reported the incident, as received through a patient notification…